This trial will examine the effects of NAC on restricted and repetitive behaviors in children with autism, using a double-blind, placebo-controlled study. Results may help explain how NAC can reduce symptom severity.
2 Primary · 2 Secondary · Reporting Duration: Baseline and week 12
2 Treatment Groups
1 of 2
1 of 2
48 Total Participants · 2 Treatment Groups
Primary Treatment: N-acetylcysteine · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 3 - 12 · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the participant criteria for this trial open to individuals beyond age forty?
"This medical trial stipulates that participants must have a minimum age of 3 and must not exceed the age of 12." - Anonymous Online Contributor
Who can partake in this clinical trial?
"Applicants who meet the criteria of having autism and ranging in age from 3 to 12 may participate in this medical trial. Currently, 48 patients are being accepted as part of this study." - Anonymous Online Contributor
How many participants are included in this clinical research?
"Indeed, the information posted on clinicaltrials.gov confirms that this medical trial is actively recruiting participants. The investigation was first made public on February 1st 2023 and has since been updated as of September 2nd 2023. At present, 48 patients are being enrolled from a single site." - Anonymous Online Contributor
Is this experiment actively seeking participants at the moment?
"Confirmed. According to clinicaltrials.gov, this research project is still actively seeking participants and was first posted on February 1st 2023 with its most recent update coming on the 9th of that same month. The investigators are hoping to recruit 48 individuals from a single site." - Anonymous Online Contributor